Guidelines on the use of extracorporeal photopheresis
Robert Knobler(Medical University of Vienna), Uwe Hillen(University of Duisburg-Essen), Robert Gniadecki(University of Alberta), Ingrid Wolf(Medical University of Graz), Walter Reinisch(Medical University of Vienna), Chalid Assaf(MSH Medical School Hamburg – University of Applied Sciences and Medical University), Péter Jaksch(Medical University of Vienna), Hildegard Greinix(Medical University of Graz), Lars E. French(University of Miami), Anja Jung(Städtisches Klinikum Dessau), Leena Bruckner‐Tuderman(University Medical Center Freiburg), A. Bohbot(Université de Strasbourg), Michael Hertl(Universitätsklinikum Gießen und Marburg), Petr Arenberger(Charles University), Undine Lippert(Städtisches Klinikum Dessau), L. Laroche(Centre Hospitalier de Luxembourg), Harald Gollnick(University Hospital Magdeburg), Margitta Worm(Charité - Universitätsmedizin Berlin), Ulrike Just(University Hospital Heidelberg), Piergiacomo Calzavara‐Pinton(University of Brescia), Christian Jantschitsch(Medical University of Vienna), Peter Wolf(University Hospital Heidelberg), Mark L. Barr(University of Southern California), Pietro Quaglino(Department of Medical Sciences), John A. Zic(Vanderbilt University), Evangelia Papadavid(National and Kapodistrian University of Athens), M. Bagot(Inserm), Annamari Ranki(University of Helsinki), Gösta Berlin(Linköping University), Julia Scarisbrick(University Hospital of Zurich), Johnny Ludvigsson(Linköping University), Alexander Enk(Heidelberg University), Thomas A. Luger(University Hospital Münster), Thomas Schwarz(University of Lübeck), Wolfram Sterry(Charité - Universitätsmedizin Berlin), C.‐D. Klemke(Heidelberg University), R Stadler(Johannes Wesling Klinikum Minden), Brigitte Dréno(Nantes Université), Hubert Pehamberger(Medical University of Vienna), Christos C. Zouboulis(Freie Universität Berlin)
Cited by 218
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
|New England Journal of Medicine|2014|2k